Search hospitals > Pennsylvania > Bethlehem

Lehigh Valley Hospital - Muhlenberg

Claim this profile
Bethlehem, Pennsylvania 18017
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Breast Cancer
Conducts research for Tumors
Conducts research for Lung Cancer
261 reported clinical trials
8 medical researchers
Photo of Lehigh Valley Hospital - Muhlenberg in BethlehemPhoto of Lehigh Valley Hospital - Muhlenberg in BethlehemPhoto of Lehigh Valley Hospital - Muhlenberg in Bethlehem

Summary

Lehigh Valley Hospital - Muhlenberg is a medical facility located in Bethlehem, Pennsylvania. This center is recognized for care of Cancer, Leukemia, Breast Cancer, Tumors, Lung Cancer and other specialties. Lehigh Valley Hospital - Muhlenberg is involved with conducting 261 clinical trials across 530 conditions. There are 8 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.

Area of expertise

1Cancer
Global Leader
Lehigh Valley Hospital - Muhlenberg has run 78 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Leukemia
Global Leader
Lehigh Valley Hospital - Muhlenberg has run 35 trials for Leukemia. Some of their research focus areas include:
Stage II
CD5 positive
Stage IV

Top PIs

Clinical Trials running at Lehigh Valley Hospital - Muhlenberg

Breast Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Bladder Carcinoma
Colorectal Cancer
Gastric Cancer
Multiple Myeloma
Rectal Cancer
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Lehigh Valley Hospital - Muhlenberg?
Lehigh Valley Hospital - Muhlenberg is a medical facility located in Bethlehem, Pennsylvania. This center is recognized for care of Cancer, Leukemia, Breast Cancer, Tumors, Lung Cancer and other specialties. Lehigh Valley Hospital - Muhlenberg is involved with conducting 261 clinical trials across 530 conditions. There are 8 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.